95 related articles for article (PubMed ID: 1602814)
1. Application of a PCR-mismatch technique to the BCL-2 gene: detection of point mutations in BCL-2 genes of malignancies with A t(14,18).
Tanaka S; Louie D; Kant J; Reed JC
Leukemia; 1992; 6 Suppl 3():15S-19S. PubMed ID: 1602814
[TBL] [Abstract][Full Text] [Related]
2. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.
Tanaka S; Louie DC; Kant JA; Reed JC
Blood; 1992 Jan; 79(1):229-37. PubMed ID: 1339299
[TBL] [Abstract][Full Text] [Related]
3. Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing.
Kneba M; Eick S; Herbst H; Willigeroth S; Pott C; Bolz I; Bergholz M; Neumann C; Stein H; Krieger G
Cancer Res; 1991 Jun; 51(12):3243-50. PubMed ID: 2039999
[TBL] [Abstract][Full Text] [Related]
4. Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphomas and lymphocytic leukemias: implications for mechanisms of tumor progression.
Reed JC; Tanaka S
Leuk Lymphoma; 1993 Jun; 10(3):157-63. PubMed ID: 8220113
[TBL] [Abstract][Full Text] [Related]
5. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
[TBL] [Abstract][Full Text] [Related]
6. Sequence preservation of the third exon of the bcl-2 gene in non-Hodgkin's lymphoma: absence of somatic hypermutation.
Farrugia MM; Duan LJ; Reis MD; Ngan BY; Sawka CA; Berinstein NL
Leukemia; 1995 Apr; 9(4):643-9. PubMed ID: 7723399
[TBL] [Abstract][Full Text] [Related]
7. A non-isotopic nested polymerase chain reaction method to quantitate minimal residual disease in patients with non-Hodgkin's lymphoma.
Hétu F; Coutlée F; Roy DC
Mol Cell Probes; 1994 Dec; 8(6):449-57. PubMed ID: 7700265
[TBL] [Abstract][Full Text] [Related]
8. 5'-->3' exonuclease-based real-time PCR assays for detecting the t(14;18)(q32;21): a survey of 162 malignant lymphomas and reactive specimens.
Estalilla OC; Medeiros LJ; Manning JT; Luthra R
Mod Pathol; 2000 Jun; 13(6):661-6. PubMed ID: 10874671
[TBL] [Abstract][Full Text] [Related]
9. Sequence analysis of amplified t(14;18) chromosomal breakpoints in B-cell lymphomas.
Eick S; Krieger G; Bolz I; Kneba M
J Pathol; 1990 Oct; 162(2):127-33. PubMed ID: 2250190
[TBL] [Abstract][Full Text] [Related]
10. Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.
Welzel N; Le T; Marculescu R; Mitterbauer G; Chott A; Pott C; Kneba M; Du MQ; Kusec R; Drach J; Raderer M; Mannhalter C; Lechner K; Nadel B; Jaeger U
Cancer Res; 2001 Feb; 61(4):1629-36. PubMed ID: 11245476
[TBL] [Abstract][Full Text] [Related]
11. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
[TBL] [Abstract][Full Text] [Related]
12. [Molecular-genetic evaluation of translocation of bcl-2 gene and locus bcl-1 in selected lymphoproliferative changes].
Ptaszyński K
Ann Acad Med Stetin; 1992; 38():51-66. PubMed ID: 1290353
[TBL] [Abstract][Full Text] [Related]
13. Large variation in t(11;14)(q13;q32) and t(14;18)(q32;q21) translocation product size is confirmed by sequence analysis of PCR products.
Wickham CL; Harries LW; Sarsfield P; Joyner MV; Ellard S
Clin Lab Haematol; 2006 Aug; 28(4):248-53. PubMed ID: 16898964
[TBL] [Abstract][Full Text] [Related]
14. The t(14;18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease.
Gupta RK; Lister TA; Bodmer JG
Leukemia; 1994 Aug; 8(8):1337-41. PubMed ID: 8057670
[TBL] [Abstract][Full Text] [Related]
15. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
Weiss LM; Warnke RA; Sklar J; Cleary ML
N Engl J Med; 1987 Nov; 317(19):1185-9. PubMed ID: 3657890
[TBL] [Abstract][Full Text] [Related]
17. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
Ngan BY; Chen-Levy Z; Weiss LM; Warnke RA; Cleary ML
N Engl J Med; 1988 Jun; 318(25):1638-44. PubMed ID: 3287162
[TBL] [Abstract][Full Text] [Related]
18. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
19. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.
Chen W; Butler M; Rao PH; Chaganti SR; Louie DC; Dalla-Favera R; Chaganti RS
Oncogene; 1998 Oct; 17(13):1717-22. PubMed ID: 9796700
[TBL] [Abstract][Full Text] [Related]
20. [Molecular diagnosis in hematopoietic malignancy].
Hoshino A; Funato T; Sasaki T
Rinsho Byori; 1996 Feb; 44(2):120-5. PubMed ID: 8851193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
